28 Followers USX:NVAX - Novavax Inc Novavax Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 7 May 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)

USD 4.85    +0.14 (+2.97%)

27 Mar 2024


Loading...
Loading...
Loading...

General

CEO: Mr. Stanley Charles Erck

IPO: 1995-12-05

Headquarters: US

Employees: 1,992

Homepage

Description

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server J

About · FAQs · StocksCafe © 2024 · Privacy · Terms